Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Fengsen Liu"'
Autor:
Jiqi Shan, Wei Jing, Yu Ping, Chunyi Shen, Dong Han, Fengsen Liu, Yaqing Liu, Congcong Li, Yi Zhang
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTAnti-PD-1 antibody therapy has achieved success in tumor treatment; however, the duration of its clinical benefits are typically short. The functional state of intratumoral CD8+ T cells substantially affects the efficacy of anti-PD-1 antibody
Externí odkaz:
https://doaj.org/article/40929eb3d9084be095904ba4d74e9276
Publikováno v:
Biomarker Research, Vol 11, Iss 1, Pp 1-19 (2023)
Abstract Immune checkpoint inhibitors (ICIs) have dramatically enhanced the treatment outcomes for diverse malignancies. Yet, only 15–60% of patients respond significantly. Therefore, accurate responder identification and timely ICI administration
Externí odkaz:
https://doaj.org/article/b6c9fc84a20e4f89a81652d1e46f9689
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
Immunotherapy resistance is a major barrier in the application of immune checkpoint inhibitors (ICI) in lung adenocarcinoma (LUAD) patients. Although recent studies have found several mechanisms and potential genes responsible for immunotherapy resis
Externí odkaz:
https://doaj.org/article/7ab40b5fda1a421b81fcb452bddd45a8
Autor:
Li Yang, Aitian Li, Fengsen Liu, Qitai Zhao, Shaofei Ji, Wen Zhu, Weina Yu, Ru Zhang, Yaqing Liu, Wencai Li, Yi Zhang
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Urothelial bladder cancer (UBC) is the most common malignant tumor of the urinary system. Most patients do not benefit from treatment with immune checkpoint inhibitors, which are closely associated with immune profiling in the context of UBC. Therefo
Externí odkaz:
https://doaj.org/article/706182a8822645828f21303ab5545a90
Autor:
Yu Ping, Jiqi Shan, Yaqing Liu, Fengsen Liu, Liuya Wang, Zhangnan Liu, Jieyao Li, Dongli Yue, Liping Wang, Xinfeng Chen, Yi Zhang
Publikováno v:
Cancer Immunology, Immunotherapy. 72:1015-1027
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bba49bf480e5d433700dc4353b4ce73b
https://doi.org/10.1007/s00262-022-03308-z
https://doi.org/10.1007/s00262-022-03308-z
Publikováno v:
Molecular and cellular probes. 62
Studies have shown that patients with lung adenocarcinoma exhibit a poor prognosis, and the overall effective rate of immunotherapy is relatively low. Previous studies reported on the BPIFB2 gene have shown that it participates in immune regulation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43d69577fd5de15e59aaa02c17a6c2a8
https://pubmed.ncbi.nlm.nih.gov/35240266
https://pubmed.ncbi.nlm.nih.gov/35240266
Background Locally advanced cervical cancer (LACC), FIGO stage equal or more than IB1 is treated with chemotherapy and external beam radiotherapy followed by brachytherapy. However, treatment failure and distant metastasis still remain a major proble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c03b52c4af49ccd7de232878607da05
https://doi.org/10.21203/rs.3.rs-960348/v1
https://doi.org/10.21203/rs.3.rs-960348/v1
Autor:
Ru Zhang, Li Yang, Qitai Zhao, Weina Yu, Wencai Li, Fengsen Liu, Wen Zhu, Aitian Li, Yaqing Liu, Yi Zhang, Shaofei Ji
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology
Urothelial bladder cancer (UBC) is the most common malignant tumor of the urinary system. Most patients do not benefit from treatment with immune checkpoint inhibitors, which are closely associated with immune profiling in the context of UBC. Therefo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea53b24f012ae60d301cc1ca68a40b1b
https://www.frontiersin.org/articles/10.3389/fcell.2021.596484/full
https://www.frontiersin.org/articles/10.3389/fcell.2021.596484/full
Publikováno v:
International immunopharmacology. 96
Background Esophageal squamous cell carcinoma (ESCC) is the main pathological subtype of esophageal cancer with high incidence and mortality. Immune and stromal cells in the tumor microenvironment (TME) profoundly affect the development of ESCC. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd7e293d41ff74bf2da5a3f6e780203d
https://pubmed.ncbi.nlm.nih.gov/34162127
https://pubmed.ncbi.nlm.nih.gov/34162127
Autor:
Runzhi Huang, Penghui Yan, Xiaolong Zhu, Peizhu Hu, Peng Hu, Zongqiang Huang, Tong Meng, Huabin Yin, Jie Zhang, Fengsen Liu
Publikováno v:
Journal of neuro-oncology. 143(3)
Malignant peripheral nerve sheath tumor (MPNST) is extremely rare in soft tissue sarcoma, with a high rate of recurrence and metastasis. Due to its rarity, the epidemiological features and prognostic factors are still uncertain. Moreover, nomograms f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe414513da7d7f638045c216473d7f2
https://pubmed.ncbi.nlm.nih.gov/31089923
https://pubmed.ncbi.nlm.nih.gov/31089923